File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone

TitleMyelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone
Authors
Issue Date2006
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/35105
Citation
American Journal Of Hematology, 2006, v. 81 n. 6, p. 471-473 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/148463
ISSN
2015 Impact Factor: 5.0
2015 SCImago Journal Rankings: 1.761
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorAu, WYen_HK
dc.contributor.authorChan, LCen_HK
dc.contributor.authorLiang, Ren_HK
dc.contributor.authorKwong, YLen_HK
dc.date.accessioned2012-05-29T06:13:07Z-
dc.date.available2012-05-29T06:13:07Z-
dc.date.issued2006en_HK
dc.identifier.citationAmerican Journal Of Hematology, 2006, v. 81 n. 6, p. 471-473en_HK
dc.identifier.issn0361-8609en_HK
dc.identifier.urihttp://hdl.handle.net/10722/148463-
dc.languageengen_US
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/35105en_HK
dc.relation.ispartofAmerican Journal of Hematologyen_HK
dc.rightsAmerican Journal of Hematology. Copyright © John Wiley & Sons, Inc.-
dc.subject.meshAntineoplastic Agents - Administration & Dosage - Adverse Effectsen_US
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols - Administration & Dosage - Adverse Effectsen_US
dc.subject.meshDexamethasone - Administration & Dosage - Adverse Effectsen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshLeukemia, Myeloid, Acute - Chemically Induceden_US
dc.subject.meshLymphoma, B-Cell - Complications - Drug Therapyen_US
dc.subject.meshLymphoma, T-Cell - Complications - Drug Therapyen_US
dc.subject.meshMaleen_US
dc.subject.meshMitoxantrone - Administration & Dosage - Adverse Effectsen_US
dc.subject.meshMyelodysplastic Syndromes - Chemically Induceden_US
dc.subject.meshNeoplasms, Second Primary - Chemically Induceden_US
dc.subject.meshVidarabine - Administration & Dosage - Adverse Effects - Analogs & Derivativesen_US
dc.titleMyelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasoneen_HK
dc.typeArticleen_HK
dc.identifier.emailChan, LC:chanlc@hkucc.hku.hken_HK
dc.identifier.emailLiang, R:rliang@hku.hken_HK
dc.identifier.emailKwong, YL:ylkwong@hku.hken_HK
dc.identifier.authorityChan, LC=rp00373en_HK
dc.identifier.authorityLiang, R=rp00345en_HK
dc.identifier.authorityKwong, YL=rp00358en_HK
dc.description.naturelink_to_OA_fulltexten_US
dc.identifier.doi10.1002/ajh.20599en_HK
dc.identifier.pmid16680740-
dc.identifier.scopuseid_2-s2.0-33646895201en_HK
dc.identifier.hkuros118861-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-33646895201&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume81en_HK
dc.identifier.issue6en_HK
dc.identifier.spage471en_HK
dc.identifier.epage473en_HK
dc.identifier.isiWOS:000237837000019-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridAu, WY=7202383089en_HK
dc.identifier.scopusauthoridChan, LC=7403540707en_HK
dc.identifier.scopusauthoridLiang, R=26643224900en_HK
dc.identifier.scopusauthoridKwong, YL=7102818954en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats